Avalon Investment & Advisory Amgen Inc Transaction History

Avalon Investment & Advisory

$3.56 Billion
Q1 2023

A detailed history of Avalon Investment & Advisory transactions in Amgen Inc stock. As of the latest transaction made, Avalon Investment & Advisory holds 102,009 shares of AMGN stock, worth $32.2 Million. This represents 0.69% of its overall portfolio holdings.

Number of Shares

102,009

Previous 95,226 7.12%

Holding current value

$32.2 Million

Previous $25 Million 1.4%

% of portfolio

0.69%

Previous 0.71%

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	BUY	$225.79 - $275.2 $1.53 Million - $1.87 Million	6,783 Added 7.12%	102,009 $24.7 Million
Q4 2022 Feb 13, 2023	SELL	$229.03 - $291.01 $177,727 - $225,823	-776 Reduced 0.81%	95,226 $25 Million
Q3 2022 Nov 01, 2022	SELL	$224.46 - $253.15 $7.93 Million - $8.94 Million	-35,309 Reduced 26.89%	96,002 $21.6 Million
Q2 2022 Aug 10, 2022	SELL	$230.71 - $256.74 $4.76 Million - $5.29 Million	-20,619 Reduced 13.57%	131,311 $31.9 Million
Q1 2022 May 17, 2022	BUY	$219.27 - $242.57 $933,870 - $1.03 Million	4,259 Added 2.88%	151,930 $36.7 Million
Q4 2021 Feb 14, 2022	BUY	$198.88 - $227.6 $3.98 Million - $4.56 Million	20,034 Added 15.7%	147,671 $33.2 Million
Q3 2021 Nov 08, 2021	SELL	$212.27 - $248.7 $2.8 Million - $3.28 Million	-13,184 Reduced 9.36%	127,637 $27.1 Million
Q2 2021 Jul 29, 2021	SELL	$233.58 - $259.14 $3.26 Million - $3.62 Million	-13,978 Reduced 9.03%	140,821 $34.3 Million
Q1 2021 May 13, 2021	SELL	$221.91 - $258.6 $12.1 Million - $14.1 Million	-54,481 Reduced 26.03%	154,799 $38.5 Million
Q4 2020 Feb 08, 2021	SELL	$216.38 - $257.67 $10.5 Million - $12.5 Million	-48,552 Reduced 18.83%	209,280 $48.1 Million
Q3 2020 Nov 04, 2020	BUY	$234.65 - $260.95 $7.07 Million - $7.86 Million	30,114 Added 13.22%	257,832 $65.5 Million
Q2 2020 Aug 07, 2020	SELL	$197.81 - $242.74 $116,905 - $143,459	-591 Reduced 0.26%	227,718 $53.7 Million
Q1 2020 May 05, 2020	BUY	$182.24 - $241.7 $1.96 Million - $2.59 Million	10,735 Added 4.93%	228,309 $46.3 Million
Q4 2019 Feb 14, 2020	SELL	$189.21 - $243.2 $157,990 - $203,072	-835 Reduced 0.38%	217,574 $52.5 Million
Q3 2019 Nov 14, 2019	BUY	$174.11 - $208.62 $929,050 - $1.11 Million	5,336 Added 2.5%	218,409 $42.3 Million
Q2 2019 Aug 14, 2019	BUY	$166.7 - $195.41 $3.94 Million - $4.62 Million	23,634 Added 12.48%	213,073 $39.3 Million
Q1 2019 Apr 24, 2019	SELL	$180.87 - $203.88 $4.86 Million - $5.48 Million	-26,857 Reduced 12.42%	189,439 $36 Million
Q4 2018 Feb 14, 2019	BUY	$178.4 - $208.25 $15.2 Million - $17.7 Million	85,103 Added 64.87%	216,296 $42.1 Million
Q3 2018 Nov 14, 2018	BUY	$185.29 - $208.89 $926,820 - $1.04 Million	5,002 Added 3.96%	131,193 $27.2 Million
Q2 2018 Aug 14, 2018	SELL	$166.05 - $186.51 $801,025 - $899,724	-4,824 Reduced 3.68%	126,191 $23.3 Million
Q1 2018 Jun 26, 2018	SELL	$169.43 - $198.0 $158,078 - $184,734	-933 Reduced 0.71%	131,015 $22.3 Million
Q1 2018 Jun 22, 2018	SELL	$169.43 - $198.0 $408,665 - $477,576	-2,412 Reduced 1.8%	131,948 $22.9 Million
Q1 2018 May 15, 2018	BUY	$169.43 - $198.0 $408,665 - $477,576	2,412 Added 1.83%	134,360 $22.9 Million
Q4 2017 Jun 22, 2018	SELL	$168.79 - $188.59 $1.1 Million - $1.23 Million	-6,497 Reduced 4.69%	131,948 $22.9 Million
Q4 2017 Feb 14, 2018	SELL	$168.79 - $188.59 $363,742 - $406,411	-2,155 Reduced 1.53%	138,445 $24.1 Million
Q3 2017 Nov 14, 2017	SELL	$167.29 - $191.0 $54,871 - $62,648	-328 Reduced 0.23%	140,600 $26.2 Million
Q2 2017 Aug 14, 2017	BUY	N/A	140,928	140,928 $24.3 Million

Others Institutions Holding AMGN

# of Institutions

3,075

Shares Held

417M

Call Options Held

7.19M

Put Options Held

6.28M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $169B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Avalon Investment & Advisory, based on Form 13F filings with the SEC.

News

Stay updated on Avalon Investment & Advisory with notifications on news.

Account

Avalon Investment & Advisory Amgen Inc Transaction History